3i Group PLC

Отворен

СекторИндекси

2,194.5 2.12

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2032

Максимум

2245

Ключови измерители

By Trading Economics

Приходи

3.3B

Продажби

192M

P/E

Средно за сектора

3.755

23.097

EPS

3.4

Дивидентна доходност

3.14

Марж на печалбата

1,711.979

Служители

223

EBITDA

2.8B

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+35.11% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.14%

2.94%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

25B

Предишно отваряне

2192.38

Предишно затваряне

2194.5

Настроения в новините

By Acuity

47%

53%

13 / 26 Класиране в Indices

3i Group PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.05.2026 г., 08:38 ч. UTC

Печалби
Значими двигатели на пазара

3i Group Shares Plunge After Slowdown at Retailer Action

29.01.2026 г., 16:27 ч. UTC

Значими двигатели на пазара

U.K. Private Equity Group 3i's Shares Surge on Strong Sales at Key Asset

13.11.2025 г., 10:02 ч. UTC

Печалби
Значими двигатели на пазара

3i Group Shares Tumble After Cautious Outlook

14.05.2026 г., 09:08 ч. UTC

Пазарно говорене
Печалби

3i Group Suffers as Problems Mount at Retailer Action -- Market Talk

14.05.2026 г., 07:04 ч. UTC

Пазарно говорене
Печалби

3i Group Buyback Might Be Eclipsed by Concerns on Key Holding Action -- Market Talk

14.05.2026 г., 06:07 ч. UTC

Печалби

3i Group: Private Equity Business Delivered Gross Investment Return of GBP5.30B in FY26

14.05.2026 г., 06:06 ч. UTC

Печалби

3i Group: Action Remained Significant Driver of Group's Performance in FY26

14.05.2026 г., 06:05 ч. UTC

Печалби

3i Group: FY2026 Total Return of GBP5.30B

14.05.2026 г., 06:05 ч. UTC

Печалби

3i Group Received GBP1.9B of Cash Proceeds From Portfolio in FY 2026

14.05.2026 г., 06:04 ч. UTC

Печалби

3i Group: Expect to See an Increase in Inflation Over Coming Months

14.05.2026 г., 06:04 ч. UTC

Печалби

3i Group: Market Environment Remains Complex Due to Middle East Situation

14.05.2026 г., 06:03 ч. UTC

Печалби

3i Group Declares Second Interim Dividend of 48p a Share

14.05.2026 г., 06:02 ч. UTC

Печалби

3i Group Plans Buyback of Up to GBP750M

14.05.2026 г., 06:00 ч. UTC

Печалби

3i FY Pretax Pft GBP5.29B

14.05.2026 г., 06:00 ч. UTC

Печалби

3i FY NAV/Shr GBP30.30

14.05.2026 г., 06:00 ч. UTC

Печалби

3i FY Net Pft GBP5.29B

14.05.2026 г., 06:00 ч. UTC

Печалби

3i FY EPS GBP5.386

26.03.2026 г., 14:12 ч. UTC

Пазарно говорене
Значими събития в новините

Action, 3i Group's Flagship Holding, Suffers from Bleak Outlook for Discount Retailers -- Market Talk

29.01.2026 г., 14:18 ч. UTC

Пазарно говорене
Печалби

3i Group's Value Proposition Built on Discount Retailer -- Market Talk

29.01.2026 г., 08:47 ч. UTC

Пазарно говорене
Печалби

3i Faces Tough Conditions in France, Competition from Chinese E-Tailers -- Market Talk

29.01.2026 г., 07:06 ч. UTC

Печалби

3i Group Gross Cash at Dec. 31 GBP995M

29.01.2026 г., 07:04 ч. UTC

Печалби

3i Group: Action Gross Cash at Dec. 31 Was EUR807M

29.01.2026 г., 07:02 ч. UTC

Печалби

3i Group: Action LFL Sales Up 6.1% in First Four Weeks of Jan

29.01.2026 г., 07:01 ч. UTC

Печалби

3i Group: Action's Like-For-Like Sales Growth Was 4.9%

29.01.2026 г., 07:01 ч. UTC

Печалби

3i Group: Action Net Sales, Operating Ebitda Rose 16% and 14%

29.01.2026 г., 07:00 ч. UTC

Печалби

3i Group NAV Per Shr Rose to 3,017 Pence

13.11.2025 г., 07:29 ч. UTC

Печалби

3i Group: First Div Is Set at 50% of Total Div for FY2025

13.11.2025 г., 07:29 ч. UTC

Печалби

3i Group PLC Declares Dividend of 36.5p

13.11.2025 г., 07:28 ч. UTC

Печалби

3i Group Had Net Debt of GBP772M, Gearing of 3%

13.11.2025 г., 07:28 ч. UTC

Печалби

3i Group Ended Period With Liquidity of GBP1.64B

3i Group PLC Прогноза

Ценова цел

By TipRanks

35.11% нагоре

12-месечна прогноза

Среден 3,271 GBX  35.11%

Висок 4,280 GBX

Нисък 1,950 GBX

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за 3i Group PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

5 ratings

3

Купи

0

Задържане

2

Продай

Настроение

By Acuity

13 / 26 Класиране в Индекси

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat